<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-184
Date of Submission: 2024-11-24

This report was submitted by a Physician from Collins-Dawson Medical Center concerning patient ANON-PX-7749. The subject is a 63-year-old other with a significant medical history including anxiety, atrial fibrillation. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Ibuprofen (NSAID) administered via the Intravenous route at a dosage of 57mg, initiated on 2024-10-05 for Pain and inflammation and discontinued on 2024-11-16.

On approximately 2024-11-14, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Vomiting, Maculopapular Rash, Nausea. The Vomiting was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed discussion and advised sound. The current patient status regarding this symptom is 'Unknown'. The Maculopapular Rash was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. The Nausea was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 2 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Send positive and between necessary Congress they. Close right because his budget foreign very.</data>
report_id: ADR-2024-184
report_date: '2024-11-24'
patient_details:
  patient_id: ANON-PX-7749
  gender: Other
  relevant_history:
  - anxiety
  - atrial fibrillation
  age_at_reaction: 63
suspected_drugs:
- drug_name: Ibuprofen
  dosage: 57mg
  route_of_administration: Intravenous
  start_date: '2024-10-05'
  indication_for_use: Pain and inflammation
  drug_class: NSAID
  end_date: '2024-11-16'
adverse_reactions:
- symptom_name: Vomiting
  onset_date: '2024-11-14'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed discussion and advised sound.
- symptom_name: Maculopapular Rash
  onset_date: '2024-11-14'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: false
- symptom_name: Nausea
  onset_date: '2024-11-14'
  severity: Mild
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Not applicable
  naranjo_score: 2
reporting_facility: Collins-Dawson Medical Center
reporter_type: Physician
notes: Send positive and between necessary Congress they. Close right because his
  budget foreign very.
